blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2417251

EP2417251 - METHOD FOR PURIFYING THE RABIES VIRUS [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  08.05.2015
Database last updated on 24.08.2024
Most recent event   Tooltip22.06.2018Lapse of the patent in a contracting state
New state(s): MK
published on 25.07.2018  [2018/30]
Applicant(s)For all designated states
Sanofi Pasteur
2, avenue Pont Pasteur
69367 Lyon Cedex 07 / FR
[2012/07]
Inventor(s)01 / FABRE, Virginie
9 Cours Lafayette
F-69006 Lyon / FR
02 / ROCCA, Céline
Le Bourg
F-69690 Bibost / FR
03 / RIFFARD, Pierre
40 allée des Prés Verts
F-69380 Dommartin / FR
04 / CALVOSA, Eric
La Grand Croix
F-69610 Haute Rivoire / FR
 [2012/10]
Former [2012/07]01 / FABRE, Virginie
45 rue Juliette Récamier
F-69006 Lyon / FR
02 / ROCCA, Céline
Le Bourg
F-69690 Bibost / FR
03 / RIFFARD, Pierre
40 allée des Prés Verts
F-69380 Dommartin / FR
04 / CALVOSA, Eric
La Grand Croix
F-69610 Haute Rivoire / FR
Application number, filing date10723229.008.04.2010
WO2010FR50679
Priority number, dateFR2009005231008.04.2009         Original published format: FR 0952310
US20090231394P05.08.2009         Original published format: US 231394 P
[2012/07]
Filing languageFR
Procedural languageFR
PublicationType: A1 Application with search report
No.:WO2010116096
Date:14.10.2010
Language:FR
[2010/41]
Type: A1 Application with search report 
No.:EP2417251
Date:15.02.2012
Language:FR
The application published by WIPO in one of the EPO official languages on 14.10.2010 takes the place of the publication of the European patent application.
[2012/07]
Type: B1 Patent specification 
No.:EP2417251
Date:02.07.2014
Language:FR
[2014/27]
Search report(s)International search report - published on:EP14.10.2010
ClassificationIPC:C12N7/02, A61K39/205
[2012/07]
CPC:
C12N7/00 (EP,US); A61K39/205 (US); A61P31/14 (EP);
A61K39/12 (US); C12N2760/20134 (US); C12N2760/20151 (EP,US)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   SE,   SI,   SK,   SM,   TR [2012/07]
Extension statesALNot yet paid
BANot yet paid
MENot yet paid
RSNot yet paid
TitleGerman:VERFAHREN ZUR AUFREINIGUNG DES TOLLWUTVIRUS[2012/07]
English:METHOD FOR PURIFYING THE RABIES VIRUS[2012/07]
French:PROCEDE DE PURIFICATION DU VIRUS RABIQUE[2012/07]
Entry into regional phase08.11.2011National basic fee paid 
08.11.2011Designation fee(s) paid 
08.11.2011Examination fee paid 
Examination procedure08.11.2011Examination requested  [2012/07]
04.06.2012Amendment by applicant (claims and/or description)
23.07.2012Despatch of a communication from the examining division (Time limit: M04)
03.12.2012Reply to a communication from the examining division
16.01.2014Communication of intention to grant the patent
19.05.2014Fee for grant paid
19.05.2014Fee for publishing/printing paid
19.05.2014Receipt of the translation of the claim(s)
Divisional application(s)EP14170027.8  / EP2806024
The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  23.07.2012
Opposition(s)07.04.2015No opposition filed within time limit [2015/24]
Fees paidRenewal fee
02.05.2012Renewal fee patent year 03
12.04.2013Renewal fee patent year 04
25.03.2014Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU08.04.2010
CY02.07.2014
CZ02.07.2014
EE02.07.2014
HR02.07.2014
LT02.07.2014
LV02.07.2014
MC02.07.2014
MK02.07.2014
MT02.07.2014
RO02.07.2014
SI02.07.2014
SK02.07.2014
SM02.07.2014
BG02.10.2014
[2018/30]
Former [2017/38]HU08.04.2010
CY02.07.2014
CZ02.07.2014
EE02.07.2014
HR02.07.2014
LT02.07.2014
LV02.07.2014
MC02.07.2014
MT02.07.2014
RO02.07.2014
SI02.07.2014
SK02.07.2014
SM02.07.2014
BG02.10.2014
Former [2017/03]CY02.07.2014
CZ02.07.2014
EE02.07.2014
HR02.07.2014
LT02.07.2014
LV02.07.2014
MC02.07.2014
MT02.07.2014
RO02.07.2014
SI02.07.2014
SK02.07.2014
BG02.10.2014
Former [2016/01]CY02.07.2014
CZ02.07.2014
EE02.07.2014
HR02.07.2014
LT02.07.2014
LV02.07.2014
MC02.07.2014
RO02.07.2014
SI02.07.2014
SK02.07.2014
BG02.10.2014
Former [2015/50]CY02.07.2014
CZ02.07.2014
EE02.07.2014
HR02.07.2014
LT02.07.2014
LV02.07.2014
RO02.07.2014
SI02.07.2014
SK02.07.2014
BG02.10.2014
Former [2015/23]CY02.07.2014
CZ02.07.2014
EE02.07.2014
HR02.07.2014
LT02.07.2014
LV02.07.2014
RO02.07.2014
SK02.07.2014
BG02.10.2014
Former [2015/22]CY02.07.2014
CZ02.07.2014
HR02.07.2014
LT02.07.2014
LV02.07.2014
RO02.07.2014
BG02.10.2014
Former [2015/12]CY02.07.2014
CZ02.07.2014
HR02.07.2014
LT02.07.2014
LV02.07.2014
BG02.10.2014
Former [2015/11]CY02.07.2014
CZ02.07.2014
LT02.07.2014
BG02.10.2014
Former [2015/10]CZ02.07.2014
LT02.07.2014
BG02.10.2014
Former [2015/08]LT02.07.2014
Cited inInternational search[YD]EP0171771  (CHEMO SERO THERAPEUT RES INST [JP]) [YD] 1-16 * page 3, line 1 - line 8; claims 3,5 * * page 6 - page 7 *;
 [YD]WO9706243  (PASTEUR MERIEUX SERUMS VACC [FR], et al) [YD] 1-16 * page 3; claims 1-4,7-9 *;
 [A]EP1724338  (CRUCELL HOLLAND BV [NL]) [A] 1* paragraph [0036] *;
 [Y]WO2008071774  (CYTOS BIOTECHNOLOGY AG [CH], et al) [Y] 1-16 * page 11, paragraph 43; claims 7-10 *;
 [XD]  - FRAZATTI-GALLINA N M ET AL, "Vero-cell rabies vaccine produced using serum-free medium", VACCINE, BUTTERWORTH SCIENTIFIC. GUILDFORD, GB, (20041209), vol. 23, no. 4, ISSN 0264-410X, pages 511 - 517, XP004629187 [XD] 17-19 * abstract *

DOI:   http://dx.doi.org/10.1016/j.vaccine.2004.06.014
 [Y]  - JUNGBAUER ET AL, "Polymethacrylate monoliths for preparative and industrial separation of biomolecular assemblies", JOURNAL OF CHROMATOGRAPHY, ELSEVIER SCIENCE PUBLISHERS B.V. AMSTERDAM, NL, (20080109), vol. 1184, no. 1-2, ISSN 0021-9673, pages 62 - 79, XP022503329 [Y] 1-16 * figures 2,3,16 * * page 72, column R * * page 75, column R - page 76, column L * * table 5 *

DOI:   http://dx.doi.org/10.1016/j.chroma.2007.12.087
by applicant   - KUMAR A.P, "Threshold Total DNA assay", MICROBES AND INFECTION, (2005), vol. 7, pages 1110 - 1116
    - FRAZATTI-GALLINA N.M., VACCINE, (2004), vol. 23, pages 511 - 517
    - JOURNAL OF CLINICAL INVESTIGATION, (1989), vol. 84, pages 971 - 975
    - BIOLOGICALS, (2003), vol. 31, pages 9 - 16
    - LEBRON J.A., DEVELOPMENTS IN BIOLOGICALS, (2006), vol. 123, pages 35 - 44
    - SWANSON MC, JOURNAL OF INFECTIOUS DISEASE, (1987), vol. 155, no. 5, pages 909 - 913
    - LEBRON J.A., COLL. DANS DEVELOPMENTS IN BIOLOGICALS, (2006), vol. 123, pages 35 - 44
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.